Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067158 · ClinicalTrials.gov registry record · Phase 3
Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1
A Phase 3 study, sponsored by New York University.
- Completed
- Registry status
- Phase 3
- Development phase
- 585
- Enrollment target
NCT00067158 is a Phase 3 study that has completed, run by New York University. The registered enrollment target is 585 participants.
The verdict
NCT00067158, a Phase 3 study, has completed, sponsored by New York University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 585 participants
- Enrollment target
Study Summary
The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.
Interventions
- DRUG nicotine transdermal system
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 585 participants |
| Start Date | 2003-04 |
| Est. Completion | 2004-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00067158
The ClinicalTrials.gov registry entry for NCT00067158 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 585 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is New York University, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which nicotine transdermal system is the first listed.
NCT00067158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00067158 about?
NCT00067158 is a clinical study titled "Smoking Cessation Treatment With Transdermal Nicotine Replacement Therapy - 1". The purpose of this study is to look at how feasible it is to incorporate a state-of-the-art smoking cessation treatment program into community substance abuse treatment programs and its impact on substance abuse and cigarette smoking.
What is the current status of trial NCT00067158?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 585 participants. The study started on 2003-04. Estimated completion is 2004-07.
What interventions are being tested in trial NCT00067158?
The interventions under investigation include: nicotine transdermal system (DRUG).
Who is sponsoring clinical trial NCT00067158?
This trial is sponsored by New York University, which has 83 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.